Estimates Revisions Northwest Biotherapeutics, Inc.
Stocks
NWBO
US66737P6007
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1840 USD | +0.29% |
|
+0.55% | -19.58% |
| 05-15 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Northwest Biotherapeutics Establishes Dedicated Leukapheresis Clinic | CI |
Turnover - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | - | ||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- NWBO Stock
- Consensus Northwest Biotherapeutics, Inc.
- Estimates Revisions
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
